ABSTRACT
The purpose of this study was to examine impact of corporate social responsibility on firm performance in Nigeria. Specifically, the study examined the impact of corporate social responsibility cost, environmental reporting, goodwill, employee benefit expense, research and development cost on firm performance of quoted pharmaceutical firms in Nigeria.
A multiple regression estimation approach was employed on information extracted from a sample consisting of fifteen (15) listed companies of the Nigerian Stock Exchange between the years 2012 to 2019. The sampled companies comprised of ten (10) banks and five (5) pharmaceutical companies, the convenient sampling technique will be utilized in selecting each of the companies. Panel Least Square (PLS) regression technique was employed in estimating the data and testing the formulated hypotheses.
The findings revealed that environmental reporting and goodwill has significant effect on performance of quoted firms in Nigeria, while corporate social responsibility cost, employee benefit expense as well as research and development cost has no significant effect on performance of quoted firms in Nigeria.
In line with the findings, the study recommended that government as well as regulatory authorities of corporate organizations should make the issue of corporate social responsibility mandatory/compulsory for the entire listed companies in Nigeria. This will compel the companies to give back to the society in which they operate and polluted by the activities of their operations, which will in turn enhance their firm performance.
